Press Releases & Statements

Title	Topic	Date
Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre	Statement COVID-19	6/22/2021
Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum	Corporate and Finance	6/17/2021
Novavax to Participate in National Vaccine Advisory Committee Meeting	Corporate and Finance	6/17/2021
Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously	COVID-19 Seasonal Influenza	6/14/2021
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial	COVID-19	6/14/2021
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine	COVID-19	6/11/2021
Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters	Corporate and Finance	6/9/2021
Novavax to Participate in Panel at BIO Digital 2021	COVID-19	6/7/2021
Novavax to Participate in Jefferies Virtual Healthcare Conference	COVID-19	5/27/2021
Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update	COVID-19	5/24/2021